Bank of New York Mellon’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Sell |
|
|||||
|
2025
Q1 | $231K | Sell |
|
|||||
|
2024
Q4 | $483K | Sell |
|
|||||
|
2024
Q3 | $1.05M | Sell |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $2.22M | Sell |
|
|||||
|
2023
Q4 | $1.2M | Buy |
|
|||||
|
2023
Q3 | $663K | Sell |
|
|||||
|
2023
Q2 | $1.54M | Sell |
|
|||||
|
2023
Q1 | $2.02M | Sell |
|
|||||
|
2022
Q4 | $3.66M | Sell |
|
|||||
|
2022
Q3 | $8.75M | Buy |
|
|||||
|
2022
Q2 | $8.69M | Sell |
|
|||||
|
2022
Q1 | $13.8M | Sell |
|
|||||
|
2021
Q4 | $21M | Buy |
|
|||||
|
2021
Q3 | $20.3M | Buy |
|
|||||
|
2021
Q2 | $28.4M | Buy |
|
|||||
|
2021
Q1 | $25.1M | Sell |
|
|||||
|
2020
Q4 | $28.7M | Sell |
|
|||||
|
2020
Q3 | $12.6M | Buy |
|
|||||
|
2020
Q2 | $9.73M | Sell |
|
|||||
|
2020
Q1 | $6.3M | Buy |
|
|||||
|
2019
Q4 | $4.67M | Buy |
|
|||||
|
2019
Q3 | $3.39M | Sell |
|
|||||
|
2019
Q2 | $4.7M | Sell |
|
|||||
|
2019
Q1 | $4.41M | Buy |
|
|||||
|
2018
Q4 | $3.15M | Sell |
|
|||||
|
2018
Q3 | $4.34M | Sell |
|
|||||
|
2018
Q2 | $3.29M | Buy |
|
|||||
|
2018
Q1 | $2.7M | Buy |
|
|||||
|
2017
Q4 | $931K | Sell |
|
|||||
|
2017
Q3 | $606K | Sell |
|
|||||
|
2017
Q2 | $511K | Buy |
|
|||||
|
2017
Q1 | $271K | Buy |
|
|||||
|
2016
Q4 | $147K | Sell |
|
|||||
|
2016
Q3 | $191K | Sell |
|
|||||
|
2016
Q2 | $117K | Buy |
|
|||||
|
2016
Q1 | $114K | Buy |
|
|||||
|
2015
Q4 | $213K | Hold |
|
|||||
|
2015
Q3 | $338K | Buy |
|
|||||
|
2015
Q2 | $270K | Buy |
|
|||||
|
2015
Q1 | $188K | Hold |
|
|||||
|
2014
Q4 | $193K | Hold |
|
|||||
|
2014
Q3 | $196K | Hold |
|
|||||
|
2014
Q2 | $242K | Buy |
|
|||||
|
2014
Q1 | $374K | Buy |
|